• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 17, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

New ‘carbs study’ shows salacia extract helps curb appetite and manage blood sugar

Bioengineer by Bioengineer
August 30, 2017
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: OmniActive

Morristown, N.J., Aug. 30, 2017 – In the recent CARBS (an acronym for Carbohydrate, Appetite Reduction, Blood Sugar and Satiety) study, researchers at Rutgers University observed that a proprietary salacia extract demonstrated appetite reduction, satiety and blood sugar management benefits. Native to the Indian subcontinent, salacia is a genus of woody climbers well known for its traditional use in Ayurveda as a medicinal food supplement for various health conditions. The recent paper, Appetite and gut hormones response to a putative α-glucosidase inhibitor, Salacia chinensis, in overweight/obese adults: a double blind randomized controlled trial, published in the journal Nutrients discussed the findings of the CARBS (an acronym for Carbohydrate, Appetite Reduction, Blood Sugar and Satiety) Study.

CARBS was a randomized, double blind, placebo-controlled, 3-way cross-over study and the first to examine the effects of a proprietary extract of Salacia chinensis (from OmniLean) on glycemic indices and gut hormones after a meal. OmniLean, taken with a meal, resulted in an improved glycemic response and changes in gut hormones in healthy overweight/obese individuals, thereby reducing blood sugar spikes and impacting appetite and satiety.

"The herb, Salacia chinensis, was shown to reduce glycemic indices and affect gut peptides after a meal. What does this mean? It means Salacia chinensis from OmniLean may be an appetite modulator, and because it lowers glycemic indices, would be beneficial to persons at risk for diabetes including overweight/obese person," said Sue A. Shapses, Ph.D., R.D., one of the lead researchers on the CARBS Study.

This type of research is good news considering the latest, startling statistics on the obesity pandemic. A 2017 report by CNN stated that one-third of the people in the world are currently obese or overweight, and if this trend continues, it has been estimated that almost half of the global population may be obese or overweight 2030 (Global Panel on Agriculture and Food Systems for Nutrition).

"The myriad complexities of being overweight need to be addressed by a multipronged approach including diet and exercise, but may also benefit greatly by making a small change such as incorporating a natural supplement like OmniLean to your daily regiment," said Abhijit Bhattacharya, President of OmniActive Health Technologies Ltd., producers of OmniLean Salacia Extract. "The CARBS Study demonstrated that OmniLean reduced the feeling of hunger and reduced spikes in blood sugar — key components of weight management — which may be the missing piece for a vast population struggling with maintaining a healthy weight."

###

For more information on the CARBS Study or OmniLean, please contact Sara Zoet at [email protected].

Media Contact

Christopher Andraka
[email protected]
908-500-1737
@OmniActive_Life

http://omniactives.com/

Share12Tweet8Share2ShareShareShare2

Related Posts

Dr. Carl Nathan Honored with David and Beatrix Hamburg Award

Dr. Carl Nathan Honored with David and Beatrix Hamburg Award

September 17, 2025
New Study Explores the Link Between Lipid Metabolism and Parkinson’s Disease

New Study Explores the Link Between Lipid Metabolism and Parkinson’s Disease

September 17, 2025

Magnetic Fields Enhance Monascus Pigment Production and Suppress Citrinin by Modulating Iron Metabolism

September 17, 2025

Single-Cell Rice Atlas Uncovers Cis-Regulatory Evolution

September 17, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    155 shares
    Share 62 Tweet 39
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    67 shares
    Share 27 Tweet 17
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionizing Cancer Treatment: The Role of Nanomaterials and the Tumor Microenvironment

New Insights into Immunotherapy Failure Offer New Hope for Cancer Patients

Parents’ Perspectives on Neonatal Transfer Process

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.